Moneta Group Investment Advisors
HELP

Moneta Group Investment Advisors’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Moneta Group Investment Advisors’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,855
Closed -$40.1K – 654
2024
Q2 		$40.1K Sell
2,855
-142
-5% -$1.86K ﹤0.01% 603
2024
Q1 		$61.5K Buy
2,997
+1,714
+134% +$24.8K ﹤0.01% 596
2023
Q4 		$20K Buy
1,283
+6
+0.5% +$112 ﹤0.01% 561
2023
Q3 		$25.8K Buy
1,277
+308
+32% +$4.53K ﹤0.01% 521
2023
Q2 		$18.4K Sell
969
-335
-26% -$4.03K ﹤0.01% 542
2023
Q1 		$19.1K Buy
1,304
+292
+29% +$4.73K ﹤0.01% 533
2022
Q4 		$14.9K Sell
1,012
-293
-22% -$4.83K ﹤0.01% 453
2022
Q3 		$24K Sell
1,305
-84
-6% -$2.27K ﹤0.01% 425
2022
Q2 		$38K Buy
+1,389
New +$33.7K ﹤0.01% 461

Other funds holding HELP

Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Logos Global Management
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
PP
PDS Planning Dublin, Ohio $1.73B AUM 24.11% 1-Year Est. Return

Moneta Group Investment Advisors's HELP Position: Q3 2024 in Review

Moneta Group Investment Advisors sold out of Helus Pharma Inc. Common Stock (HELP) in Q3 2024, closing a stake of 2,855 shares — an estimated $40.1K sold.

Moneta Group Investment Advisors first reported a position in HELP in Q2 2022 and held it in 9 quarters. The position peaked at $61.5K in Q1 2024. 46 funds tracked by Wall St. Rank hold HELP as of Q3 2024.

  • Moneta Group Investment Advisors reported no remaining Helus Pharma Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Moneta Group Investment Advisors sold 2,855 Helus Pharma Inc. Common Stock shares in Q3 2024, an estimated $40.1K.
  • Moneta Group Investment Advisors first reported a position in Helus Pharma Inc. Common Stock in Q2 2022 and held it in 9 quarters.
  • Moneta Group Investment Advisors's Helus Pharma Inc. Common Stock position peaked at $61.5K in Q1 2024.
  • 46 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q3 2024.

Based on Moneta Group Investment Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.